It’s a well-accepted truism that drug discovery is hard (only 10% of potential new drugs make it to market), expensive ($2.6B and counting), and time consuming (12 years from bench to bedside).
A Medical Monitor’s top priority is to protect clinical trial subjects by monitoring safety signals in the data. To that end, what are your medical monitor’s processes and what technology are they using to ensure focused medical data review, increased subject safety, and accelerated productivity?
I am an apprentice working at Lancaster University as a Chemical Engineering Technician. In this capacity I study 1 day per week as well as working as a technician at the university.
We live in a world of displays: on laptops, smartphones, tablets, smartwatches. These devices bring together technologies to make our lives better, but, above all, their key feature is that they’re primarily visual.
ChemDraw is an industry leader in chemical drawing software. It is the proven chemistry drawing suite for researchers, students and academics.
A recent article in Chemical & Engineering News (June 4, 2018, pp 28-33) focused on activities in immuno-oncology, where biologic checkpoint inhibitors are being tested in combination with other immunotherapies: there are currently ca. 250 small molecule- and antibody-based immunotherapies in clinical studies, and > 1100 clinical trials in 2017 combined a checkpoint inhibitor with another treatment.
We then attempted to ease their pain by exploring modern informatics tools and applications that guide them to rapidly and intelligently identify, locate, search, extract and organize tractable sets of relevant data (internal or external, structured or unstructured, small molecule or biologic) for detailed analysis and visualization.
The experts at PerkinElmer have worked with thousands of customers to help them select an electronic lab notebook solution. Here are four time-tested steps to cut your search time and quickly identify the best ELN for your organization.
An “in-the-trenches” perspective on ELN is provided by guest author, Rick Betori, a National Institutes of Health Chemistry-Biology Interface Predoctoral Fellow and a Northwestern Department of Chemistry Departmental Fellow.